摘要:
An object of the present invention is to prepare an antibody that targets CAPRIN-1 specifically expressed on the surface of cancer cells and is superior in antitumor activity to conventional antibodies and to provide use of the antibody as a therapeutic and/or preventive agent for cancer. The present invention provides use of an antibody targeting an identified cancer antigenic protein specifically expressed on the surface of cancer cells as a therapeutic and/or preventive agent for cancer, specifically, a pharmaceutical composition for treatment and/or prevention of cancer, comprising as an active ingredient an antibody or a fragment thereof which has immunological reactivity with a CAPRIN-1 protein, the antibody or the fragment thereof comprising a heavy chain variable region comprising amino acid sequences represented by SEQ ID NOs: 5, 6, and 7 and a light chain variable region comprising amino acid sequences represented by SEQ ID NOs: 9, 10, and 11.
摘要:
This invention provides an antibody targeting a cancer antigenic protein specifically expressed on the surface of cancer cells and use thereof as a therapeutic and/or preventive agent for cancer. More specifically, the present invention provides an antibody, or a fragment thereof which has immunological reactivity with a CAPRIN-1 protein, the antibody comprising a heavy chain variable region comprising complementarity determining regions of SEQ ID NOs: 5, 6, and 7 and a light chain variable region comprising complementarity determining regions of SEQ ID NOs: 9, 10, and 11, and a pharmaceutical composition for treatment and/or prevention of cancer, comprising the same as an active ingredient.
摘要翻译:本发明提供靶向癌细胞表面特异性表达的癌抗原蛋白的抗体及其作为癌症治疗和/或预防剂的用途。 更具体地,本发明提供了与CAPRIN-1蛋白具有免疫反应性的抗体或其片段,所述抗体包含包含SEQ ID NO:5,6和7的互补决定区的重链可变区和 包含SEQ ID NO:9,10和11的互补决定区的轻链可变区和用于治疗和/或预防癌症的药物组合物,其包含其作为活性成分。
摘要:
An object of the present invention is to prepare an antibody that targets CAPRIN-1 specifically expressed on the surface of cancer cells and is superior in antitumor activity to conventional antibodies and to provide use of the antibody as a therapeutic and/or preventive agent for cancer. The present invention provides use of an antibody targeting an identified cancer antigenic protein specifically expressed on the surface of cancer cells as a therapeutic and/or preventive agent for cancer, specifically, a pharmaceutical composition for treatment and/or prevention of cancer, comprising as an active ingredient an antibody or a fragment thereof which has immunological reactivity with a CAPRIN-1 protein, the antibody or the fragment thereof comprising a heavy chain variable region comprising amino acid sequences represented by SEQ ID NOs: 5, 6, and 7 and a light chain variable region comprising amino acid sequences represented by SEQ ID NOs: 9, 10, and 11.
摘要翻译:本发明的目的是制备靶向癌细胞表面特异性表达的CAPRIN-1的抗体,对常规抗体具有优异的抗肿瘤活性,并提供抗体作为癌症治疗和/或预防剂的用途 。 本发明提供了靶向癌细胞表面特异表达的鉴定癌抗原蛋白的抗体作为癌症的治疗和/或预防剂的用途,特别是用于治疗和/或预防癌症的药物组合物,其包括作为 活性成分是与CAPRIN-1蛋白具有免疫反应性的抗体或其片段,所述抗体或其片段包含包含SEQ ID NO:5,6和7所代表的氨基酸序列的重链可变区和轻链 链可变区,其包含由SEQ ID NO:9,10和11表示的氨基酸序列。
摘要:
According to the present invention, a cancer antigen protein to be specifically expressed on the surfaces of cancer cells is identified and thus the use of an antibody targeting the cancer antigen protein as an agent for treating and/or preventing a cancer is provided. Specifically, the present invention provides a pharmaceutical composition for treating and/or preventing a cancer, which comprises an antibody comprising a heavy chain variable region that comprises SEQ ID NOS: 39, 40, and 41 and a light chain variable region that comprises SEQ ID NOS: 43, 44, and 45 or a fragment thereof as an active ingredient and having immunological reactivity with a CAPRIN-1 protein.
摘要翻译:根据本发明,鉴定在癌细胞表面特异性表达的癌抗原蛋白,因此提供了靶向癌抗原蛋白的抗体作为治疗和/或预防癌症的药剂的用途。 具体而言,本发明提供了用于治疗和/或预防癌症的药物组合物,其包含含有包含SEQ ID NO:39,40和41的重链可变区的抗体和包含SEQ ID NO:39,40和41的轻链可变区, NOS:43,44和45或其片段作为活性成分,并与CAPRIN-1蛋白具有免疫反应性。
摘要:
A heat treatment apparatus and control method enabling the apparatus to settle down the internal temperature of a treating vessel to a target temperature accurately and quickly. The apparatus includes a furnace body with a heater on an inner circumferential surface thereof, a treating vessel disposed inside the furnace body, a cooling medium supply blower and cooling medium release blower connected to the furnace body, and a temperature sensor provided inside the treating vessel. A signal from the temperature sensor is sent to a heater output computing unit of a controller. The computing unit determines a heater output level to be obtained during temperature regulation with the heater only, the heater output level being based on a preset temperature that has been determined by a temperature determining unit and temperature detected by the temperature sensor. A blower output computing unit activates blower output based on the heater output level.
摘要:
An ultrasonic imaging apparatus includes an image obtaining unit for irradiating an imaging region and obtaining tomographic image information that draws the imaging region, an input unit for inputting scan parameter value information and a target sound pressure parameter value as an index of an estimated sound pressure in the subject, an estimated maximum sound pressure parameter value calculating device for calculating an estimated maximum sound pressure parameter value in the subject on the basis of the scan parameter value information and maximum drive voltage information of a piezoelectric transducer group for generating an ultrasonic wave, and a maximum drive voltage optimization device for comparing the estimated maximum sound pressure parameter value and the target sound pressure parameter value and optimizing the maximum drive voltage value of the maximum drive voltage information.
摘要:
The invention relates to an immunity-inducing agent comprising, as an active ingredient, at least one polypeptide having immunity-inducing activity that is selected from among polypeptides (a), (b), and (c): (a) a polypeptide of at least seven contiguous amino acids of the amino acid sequence shown by any even SEQ ID number selected from SEQ ID NOs: 2 to 30 listed in the Sequence Listing; (b) a polypeptide of at least seven amino acids having 90% or more sequence identity with the polypeptide (a); and (c) a polypeptide comprising the polypeptide (a) or (b) as a partial sequence thereof, or a recombinant vector comprising a polynucleotide encoding said polypeptide and capable of expressing said polypeptide in vivo.
摘要翻译:本发明涉及一种免疫诱导剂,其包含作为活性成分的至少一种具有免疫诱导活性的多肽,其选自多肽(a),(b)和(c):(a)多肽 氨基酸序列的至少七个连续氨基酸由选自序列表中所列的SEQ ID NO:2至30的任何偶数SEQ ID号表示; (b)与多肽(a)具有90%或更多序列同一性的至少7个氨基酸的多肽; 以及(c)包含多肽(a)或(b)作为其部分序列的多肽,或包含编码所述多肽并能够在体内表达所述多肽的多核苷酸的重组载体。
摘要:
The invention provides thermoplastic resin compositions for purging which comprise a thermoplastic resin and a methyl methacrylate/styrene copolymer incorporated therein. According to the invention, thermoplastic resin compositions for purging molding machines, which have an excellent cleaning ability, can be obtained.
摘要:
A small-sized electric motor includes a yoke formed by bending a rectangular metallic plate into an oval shaped tube having a pair of flat parts and a pair of arcuate parts and joining opposite ends of the metallic plate. An end cap is secured on one end of the yoke and a gear casing is secured to the yoke by a tab formed on another end of the yoke. The joining faces of the metallic plate are located away from the center line of an arcuate part of the yoke and jagged faces are formed on the joining faces. The jagged faces are composed only of curved parts and straight parts having inclinations to the axis of the yoke. The end cap is secured by crimping a bendable tab formed on one end of the yoke by burring. A tab for securing the yoke to a gear box is formed by bending a tongue provided on the metallic plate together with notches on both sides of the tongue.
摘要:
A percutaneous absorption promoter comprises a derivative of amino acid in which the amino group has or does not have an acyl substituent or a hydrocarbon substituent, the carboxylic group has a hydrocarbon substituent and the part between the amino group and the carboxylic group has a specified structure. A tape plaster comprises the percutaneous absorption promoter described above. The method utilizes the the percutaneous absorption promoter described above. The percutaneous promoter of the invention has excellent ability of promoting the percutaneous absorption of pharmacologically active substances and excellent safety simultaneously, capable of delivering the desired pharmacologically active substances rapidly to the location of treatment or to all parts of the body through the circulating system and effective for curing various kinds of disease. The tape plaster comprising it and the method of promoting percutaneous absorption by utilizing it have the same advantages.